Algos MorphiDex Has Dec. 31, 2001 Deadline For FDA Approval In Endo Deal
Executive Summary
Algos has an upcoming Dec. 13 meeting with FDA regarding the future of its cancer pain treatment MorphiDex that could influence the value of the company's proposed merger with Endo Pharmaceuticals.